跳至主要内容
临床试验/CTRI/2026/04/107302
CTRI/2026/04/107302尚未招募4 期

A Comparative evaluation of Dexmedetomidine and Ketamine nebulization in preventing postoperative sore throat following endotracheal intubation

Dr Suresh Vishwanathan1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年5月1日最近更新:
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Incidence and severity of postoperative sore throat

研究概览

简要总结

Post operative sore throat(POST) is a common occurrence following general anesthesia with endotracheal intubation.

Incidence of POST is estimated to be 21%-65% in different studies. Irritation and inflammation of the airway are considered to be the causes of POST.

Although considered as a minor complication, it may cause significant patient morbidity, dissatisfaction, and increased the length of hospital stay.

Nowadays, aerosolised drugs are better accepted and tolerated by the patients than gargle, as it spares them from the bitter taste of the drug.

DEXMEDETOMIDINE is a colorless, tasteless and odorless drug with a selective alpha 2 adrenergic agonistic action, which causes sedation and analgesia.

KETAMINE is an N-methyl-D-aspartate(NMDA) receptor antagonist has anti-nociceptive and anti-inflammatory properties.

To compare the efficacy of preoperative DEXMEDETOMIDINE and KETAMINE nebulization in preventing sore throat following endotracheal intubation

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • ASA I to III patients undergoing general anaesthesia.

排除标准

  • ASA IV Pregnancy.

结局指标

主要结局

Incidence and severity of postoperative sore throat

时间窗: 0, 2, 4, 8, 12 and 24 hours

次要结局

未报告次要终点

研究者

发起方
Dr Suresh Vishwanathan
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Devashri Vasudevan

SKS Hospital and Post Graduate Medical Institiute

研究点 (1)

Loading locations...

相似试验